Global Drug
Eluting Balloon Market, by Product Type (Coronary Drug Eluting Balloon,
Peripheral Drug Eluting Balloon, and Others), by End User (Hospitals, CATH
Laboratories, Ambulatory Surgery Centers, and Others), and by Region (North
America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was
valued at US$ 420.0 Million in 2017, and is projected to exhibit a CAGR of 8.1%
over the forecast period (2018 – 2026).
Launch of novel drug eluting
balloons by market players to augment the market growth Key players in the market
are focused on launching novel drug eluting balloons in order to treat coronary
artery disease and other diseases and address the critical unmet needs of
patients. For instance, in October 2014, C.R. Bard’s received U.S. Food and
Drug Administration (FDA) approval for Lutonix 035 drug eluting balloon that is
used in popliteal arteries in upper legs. Similarly, in January 2015, Medtronic
received clearance from the U.S. FDA for In.Pact Admiral Drug eluting balloon
that is used in the superficial femoral and popliteal arteries in upper legs,
thereby providing new opportunities for Medtronic and C.R. Bard’s in offering
effective treatment options among the fastest growing markets worldwide.
* The sample copy includes:
Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report
Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/2459
In July 2017, Spectranetics Corp.
received pre-market approval (PMA) from U.S. FDA for Stellarex drug coated
balloon that is used for restoration and maintenance of blood flow to the
superficial femoral and popliteal arteries in patients with peripheral arterial
disease.
Browse 35 Market Data Tables and
28 Figures spread through 168 Pages and in-depth TOC on ‘Drug Eluting Balloon
Market’- Global Forecast to 2026, by Product Type (Coronary Drug Eluting
Balloon, Peripheral Drug Eluting Balloon, and Others), by End User (Hospitals,
CATH Laboratories, Ambulatory Surgery Centers, and Others), and by Region
(North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
Key players in the market are
focused on adopting strategies such as mergers and acquisitions to enhance
their product portfolio. For instance, in November 2014, Medtronic, Inc.
acquired Covidien, plc, a company involved in developing and manufacturing a range of medical devices
and supplies, including laproscopic surgery, electrosurgery, and vascular
therapies. Covidien sells its products in over 150 countries.
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/drug-eluting-balloon-market-2459
Key Takeaways of the Drug Eluting
Balloon Market:
The global drug eluting balloon
market is expected to exhibit a CAGR of 8.1% over the forecast period, owing to
increasing prevalence of coronary artery diseases, diabetes, and obesity,
increased use of tobacco and smoking, and increasing geriatric population prone
to cardiovascular diseases
Among product type, the
peripheral drug eluting balloon segment held a dominant position in the drug
eluting balloon market in 2018. This is owing to increasing use of drug eluting
balloon in the treatment of peripheral artery disease as the treatment shows
improved patency rate as compared to standard Percutaneous Transluminal
Angioplasty (PTA) balloons.
Among end user, hospitals and ambulatory
service centers segment held a dominant position in the drug eluting balloon
market in 2018, owing to high adoption rate of the devices in hospitals and
ambulatory service centers
Key players operating in the
global drug eluting balloon market include, Medtronic, Becton, Dickinson and
Company (BD), Boston Scientific Corporation, Cook Medical, B. Braun Melsungen
AG, Koninklijke Philips N.V., Opto Circuits (India) Limited, Terumo
Corporation, Surmodics, Inc., and Biotronik
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/2459
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
